United States Federal Circuit

The district court's holding that defendant committed inequitable conduct in obtaining a patent, involving a semi-synthesis of taxol, a cancer chemotherapeutic agent, is not an abuse of discretion, and its denial of defendant's motion for summary judgment of infringement is affirmed.

Appellate Information

• Decided 04/15/2003
• Published 04/15/2003

Judges

• PROST, Circuit Judge., Before CLEVENGER, SCHALL, and PROST, Circuit Judges.

Court

• United States Federal Circuit

Counsel

• For Appellees:
  
• Robert L. Baechtold,Fitzpatrick, Cella, Harper & Scinto, of New York, NY, argued for plaintiff-appellee.   With him on the brief were Thomas H. Beck, Dominick A. Conde, William E. Solander, and Sandy Choi., Donald R. Dunner, Finnegan, Henderson, Farabow, Garrett & Dunner, L.L.P., of Washington, DC, argued for defendants-appellants.   With him on the brief was Doris Johnson Hines.   Of counsel on the brief was Ross J. Oehler, Aventis Pharmaceuticals Inc., of Bridgewater, NJ.